반응형 Moderna stock 반응형 (1) 썸네일형 리스트형 Moderna's COVID-19 Vaccine, Phase III clinical trials. Early clinical trials by U.S. pharmaceutical company Moderna to develop a new type of coronavirus infection vaccine found that all subjects successfully formed antibodies. There is a high possibility that the Corana 19 vaccine will be released soon. Moderna, a U.S. biotech company, is the most promising company to date in the race to develop a vaccine for the virus that has crippled the global e.. 이전 1 다음